Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2014-05-22

Clinical Trial Update: Effect of Cafedrine/Theodrenaline and Urapidil on Cerebral Oxygenation [NA]

View source ↗

Summary

A clinical trial investigating the effects of cafedrine/theodrenaline and urapidil on cerebral oxygenation in cerebral ischemia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cafedrine/Theodrenaline (cafedrine/theodrenaline)
  • Urapidil (urapidil)

Snippet

Sponsor: University Hospital Schleswig-Holstein | Conditions: Cerebral Ischemia | NA | Status: WITHDRAWN